CrossrefInfokarte
Chimeric antigen receptor modified T cells directed against CD19 (CTL019) in patients with relapsed, refractory CLL: a systematic review and meta-analysis
American Journal of Blood Research · 2025
DOI: 10.62347/wdwe6603 ↗Abstract
Kein Abstract verfügbar.
EUVIMED